Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Zevra Therapeutics
Over the past year LXRX returned +6.0% and ZVRA returned +1.4%; their daily moves had a correlation of 0.18.
LXRX +6.0% ZVRA +1.4%Growth of $1, one year, split-adjusted
| Metric | LXRX | ZVRA |
|---|---|---|
| Price | $1.42 | $10.28 |
| Market cap | $631.8M | $610.5M |
| Today | −4.05% | −0.77% |
| 1 month | −22.0% | +1.0% |
| 6 months | −12.9% | +2.1% |
| Year to date | +23.5% | +14.7% |
| 1 year | +6.8% | +1.6% |
| Revenue growth (YoY) | −97.6% | +53.3% |
| Gross margin | 94.4% | 96.2% |
| Net margin | −4591.8% | 21.2% |
| P/E (TTM) | — | 10.5× |
| Price / sales | 15.3× | 4.5× |
| Net cash | $139.2M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 52.9% | 44.3% |
| Short % of float | 11.8% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).